(Q53813775)

English

Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. (English)

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

childhood cancer

1 reference

based on heuristic

inferred from title

author name string

Smith MB

1

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Xue H

2

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Strong L

3

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Takahashi H

4

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Jaffe N

5

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Ried H

6

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Zietz H

7

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Andrassy RJ

8

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

language of work or name

0 references

publication date

1 October 1993

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Journal of Pediatric Surgery

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

28

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

10

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

1342-8; discussion 1348-9

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Patterns of multiple primary tumours in patients treated for cancer during childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Incidence of second malignant neoplasms in children: results of an international study

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Cancer incidence, survival, and mortality for children younger than age 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Mortality after radiotherapy for ringworm of the scalp.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Radiation dose and second cancer risk in patients treated for cancer of the cervix.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Bone sarcomas linked to radiotherapy and chemotherapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Second malignancies following cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Second primary tumors following radiotherapy for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Melphalan may be a more potent leukemogen than cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Patterns of second malignant neoplasms in children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Trends in cancer survival among U.S. white childrn, 1955–1971

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Chemotherapy With cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for hodgkin disease: Fourteen-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Retinoblastoma: Clues to Human Oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Clinical aspects of postirradiation sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Postradiation soft tissue sarcomas. An analysis of 53 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Loss of genes on the short arm of chromosome 11 in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2805%2980325-2

7 January 2021

Identifiers

10.1016/S0022-3468(05)80325-2

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/8263699

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53813775&oldid=1967122190"